G-CSF and GM-CSF as therapeutic targets in rheumatoid arthritis (Q37607068)

21 August 2017

1 reference

title

G-CSF and GM-CSF as therapeutic targets in rheumatoid arthritis (English)

1 reference

21 August 2017

1 reference

Ann L Cornish

1

1 reference

21 August 2017

Ian K Campbell

2

1 reference

21 August 2017

Brent S McKenzie

3

1 reference

21 August 2017

Simon Chatfield

4

1 reference

21 August 2017

Ian P Wicks

5

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 October 2009

1 reference

Nature Reviews Rheumatology

21 August 2017

published in

1 reference

21 August 2017

volume

5

1 reference

21 August 2017

issue

10

1 reference

21 August 2017

page(s)

554-559

1 reference

Randomized comparison of G-CSF + GM-CSF vs G-CSF alone for mobilization of peripheral blood stem cells: effects on hematopoietic recovery after high-dose chemotherapy.

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

Granulocyte colony-stimulating factor and neutrophils--forgotten mediators of inflammatory disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

Colony-stimulating factors in inflammation and autoimmunity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

Detection of cytokines at the cartilage/pannus junction in patients with rheumatoid arthritis: implications for the role of cytokines in cartilage destruction and repair

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

IL-23 is required for neutrophil homeostasis in normal and neutrophilic mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

IL-17A controls IL-17F production and maintains blood neutrophil counts in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

Requirement of endogenous stem cell factor and granulocyte-colony-stimulating factor for IL-17-mediated granulopoiesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

G-CSF: a key regulator of neutrophil production, but that's not all!

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

SOCS-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1-dependent inflammatory arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

Neutrophil kinetics in man

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

Impaired production and increased apoptosis of neutrophils in granulocyte colony-stimulating factor receptor-deficient mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

Homeostatic regulation of blood neutrophil counts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

Expression cloning of a receptor for human granulocyte-macrophage colony-stimulating factor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

GM-CSF mediates autoimmunity by enhancing IL-6-dependent Th17 cell development and survival

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

Polymorphonuclear granulocytes at the pannus-cartilage junction in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

Microbial antigen triggers rapid mobilization of TNF-alpha to the surface of mouse neutrophils transforming them into inducers of high-level dendritic cell TNF-alpha production

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

Perpetuation of inflammation associated with experimental arthritis: the role of macrophage activation by neutrophilic myeloperoxidase.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

G-CSF-stimulated neutrophils are a prominent source of functional BLyS

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

Evidence that cytokines play a role in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

The dynamics of macrophage lineage populations in inflammatory and autoimmune diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

Innate immune recognition of infected apoptotic cells directs T(H)17 cell differentiation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

Macrophage phagocytosis of apoptotic neutrophils is critically regulated by the opposing actions of pro-inflammatory and anti-inflammatory agents: key role for TNF-α

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

A key role for G-CSF-induced neutrophil production and trafficking during inflammatory arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

Critical role for granulocyte colony-stimulating factor in inflammatory arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

GM-CSF neutralisation suppresses inflammation and protects cartilage in acute streptococcal cell wall arthritis of mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

Severe inflammatory arthritis and lymphadenopathy in the absence of TNF.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

Combined blockade of granulocyte-macrophage colony stimulating factor and interleukin 17 pathways potently suppresses chronic destructive arthritis in a tumour necrosis factor -independent mouse model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

T lymphocytes from granulocyte colony-stimulating factor-/- mice produce large quantities of interferon-gamma in a chronic infection model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

Treatment-induced stable, moderate reduction in blood cell counts correlate to disease control in early rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

Rheumatoid arthritis: opposing actions of haemopoietic growth factors and slow-acting anti-rheumatic drugs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

Pulmonary alveolar proteinosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

Granulocyte/macrophage-colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

Quantitative analysis of longitudinal response to aerosolized granulocyte-macrophage colony-stimulating factor in two adolescents with autoimmune pulmonary alveolar proteinosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

New therapies for treatment of rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

Serum cytokine profiles in relapsing polychondritis suggest monocyte/macrophage activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.178

"Emergency" granulopoiesis in G-CSF-deficient mice in response to Candida albicans infection

31 March 2020

1 reference

12 December 2020

Effects of recombinant human granulocyte colony-stimulating factor administration on neutrophil phenotype and functions.

1 reference

12 December 2020

Enhanced neutrophilic granulopoiesis in rheumatoid arthritis. Involvement of neutrophils in disease progression

1 reference

12 December 2020

The detection and initial characterization of colony-stimulating factors in synovial fluid.

1 reference

12 December 2020

High serum and synovial fluid granulocyte colony stimulating factor (G-CSF) concentrations in patients with rheumatoid arthritis

1 reference

12 December 2020

Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization

1 reference

12 December 2020

Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients.

1 reference

12 December 2020

Levels of serum granulocyte colony-stimulating factor in patients with infections

1 reference

12 December 2020

Treatment with anti-granulocyte antibodies inhibits the effector phase of experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRRHEUM.2009.178

1 reference

21 August 2017

1 reference